Top Markets
Coin of the day
Bright Minds Biosciences Inc. Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG
주식 순위 #11319
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
주가
$73.12
마지막 동기화: 2026-08-28
시가총액
$715.61M
변동 (1일)
-1.90%
변동 (1년)
88.01%
국가
US
거래 Bright Minds Biosciences Inc. (DRUG)

카테고리

Bright Minds Biosciences Inc. (DRUG)의 주식 분할 이력
Bright Minds Biosciences Inc. 주식 (심볼: DRUG)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 30, 2026에 발생했습니다.
Aug 30, 2026 이전에 매수한 DRUG 주식 1주는 현재 0주의 DRUG 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH